Top Markets
#1 ADO Protocol ADO Protocol +329.52%
#2 GoPlus Security GoPlus Security +53.72%
#3 Nockchain Nockchain +47.20%
#4 Starpower Starpower +36.50%
#5 Tutorial Tutorial +35.69%
#6 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +31.73%
#7 The Black Bull The Black Bull +29.67%
#8 GAIB AID GAIB AID +24.67%
#9 Casper Network Casper Network +21.80%
#10 Verus Coin Verus Coin +20.40%
Coin of the day
ADO Protocol ADO Protocol
設定
言語
日本
通貨
USD
テーマ
PhoenixBio Co., Ltd. PhoenixBio Co., Ltd.

PhoenixBio Co., Ltd.

6190
株式のランク #32812
PhoenixBio Co., Ltd. delivers specialized contract research services to support... PhoenixBio Co., Ltd. delivers specialized contract research services to support drug discovery and development, with a primary focus on the Japanese market. Central to its offerings is the proprietary PXB-mouse, a unique chimeric mouse model featuring a humanized liver, which is critical for various drug development experiments. The company also conducts in vitro analyses utilizing fresh human hepatocytes sourced from PXB-cells. This sophisticated humanized liver model proves invaluable for in vivo studies encompassing gene therapy, NASH/NAFLD drug development programs, anti-viral therapeutic evaluations, DMPK (Drug Metabolism and Pharmacokinetics) and toxicity assessments, and custom transplantation projects. Established in 2002, PhoenixBio maintains its headquarters in Higashihiroshima, Japan.
株価
$2.22
時価総額
$9.03M
変化（1日）
-3.13%
変化（1年）
-21.92%
国
JP
取引 PhoenixBio Co., Ltd. (6190)

カテゴリー

Healthcare
PhoenixBio Co., Ltd.（6190）のP/B比率
2026 時点のP/B比率 TTM: 0
PhoenixBio Co., Ltd. の最新の財務報告および株価によると、現在のP/B比率（TTM）は 0 です。2026 年末時点でのP/B比率は 0 でした。
PhoenixBio Co., Ltd. の P/B 比率の履歴（2026 ～ 2026）
各年末時点のP/B比率
年 P/B比率 変化
提供された日付のデータは十分ではありません。
同業他社のP/B比率
企業 P/B比率 P/B比率の差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 6.3419 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 6.2413 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 3.4612 -
BE